CoreWeave, a leading cloud computing company, acquires rival Core Scientific in a massive $9 billion all-stock deal, eliminating $10 billion in future lease obligations and gaining ownership of 1.3 gigawatts of data center capacity, solidifying its position in the rapidly growing cloud market.
Players at Wimbledon express frustration over AI line-calling technology making incorrect calls, costing them points, despite officials defending the system's accuracy over human judges.
ChatGPT introduces a groundbreaking 'Study Together' mode exclusively for subscribers, posing questions to users instead of providing direct answers, fostering an engaging educational experience and deterring academic dishonesty.
AI chatbots are increasingly being used to guide psychedelic trips, raising concerns from experts about potential dangers from machines unable to perceive subtleties during intense psychedelic experiences, despite some finding them helpful for preparation and processing.
Meta strikes a blow in the AI talent war, poaching Ruoming Pang, Apple's head of AI models who oversaw training for the tech giant's in-house AI systems, in a potential exodus from Apple's troubled artificial intelligence division.
OpenAI revises its safety guidelines, downplaying disinformation concerns and indicating it may release 'high risk' AI models if rivals have already done so, while addressing risks through terms of service and monitoring.
OpenAI fortifies defenses with measures like information tenting, biometric access controls, and offline isolation of proprietary technology to protect against corporate espionage, foreign adversaries, and internal leaks.
Groq, an AI semiconductor startup, launches its first European data center in Helsinki, Finland through a partnership with Equinix, enabling rapid expansion of AI services in Europe with the deployment taking only 4 weeks from decision to serving traffic.
Groundbreaking AI from Mayo Clinic accurately detects surgical site infections from patient photos with 94% incision and 81% infection identification rates, enabling faster response and earlier treatment.
AI startup Isomorphic Labs, spun out of DeepMind, prepares for human trials of drugs designed by cutting-edge AI paired with pharma experts, aiming for 100% conviction drugs will work before trials, promising faster, cheaper and more accurate medicine design.